Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS North America Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Preview AMS TV
Features
AMS Features
News & Publications
AMS Bookstore
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Time to meaningful clinical response in reduction of itch in atopic dermatitis
By
- AMS
posted
Dec 09, 2020 07:00 AM
0
Recommend
.
0 comments
0 views
Permalink
Related Content
Improvement in sleep and itch and enhanced quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a phase 3 trial of baricitinib therapy
- AMS
Added Jun 28, 2021
Blog Entry
Inadequate response and treatment patterns in adults diagnosed with atopic dermatitis and treated with topical therapy
- AMS
Added Oct 06, 2021
Blog Entry
Baricitinib for the treatment of atopic dermatitis
- AMS
Added Aug 24, 2021
Blog Entry
Efficacy and safety of abrocitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials
- AMS
Added Aug 13, 2021
Blog Entry
Review and analysis of biologic therapies currently in phase II and phase III clinical trials for atopic dermatitis
- AMS
Added Jun 08, 2020
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic